Meitav Dash Investments LTD Chemomab Therapeutics Ltd. Transaction History

Meitav Dash Investments LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$3.53 - $7.2 $8,976 - $18,309	-2,543 Reduced 6.77%	35,024 $167,000
Q3 2021 Nov 03, 2021	SELL	$11.08 - $19.17 $34,314 - $59,369	-3,097 Reduced 7.62%	37,567 $416,000
Q2 2021 Aug 05, 2021	BUY	$16.07 - $55.0 $519,912 - $1.78 Million	32,353 Added 389.28%	40,664 $773,000
Q1 2021 May 06, 2021	BUY	$27.2 - $127.36 $226,059 - $1.06 Million	8,311 New	8,311 $239,000

4.55M

Ticker CMMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,431,700
Market Cap $18.5M
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.